| ||||||||
|
||||||||
|
||||||||
|
||||||||
| Or | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "Y"
Results 171 - 180 of 594 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| Maeda, Y K Yamaguchi, T Shimamura, I Hyodo, W Koizumi, T Doi, H Narahara, Y Komatsu, T Kato, S Saitoh, T Akiya, M Munakata, Y Miyata, Y Maeda, H Takiuchi, S Nakano, T Esaki, F Kinjo and Y Sakata Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer doi:10.1038/sj.bjc.6603196 Abstract | Full article | PDF |
||||||||
| Mamane, Y E Petroulakis, Y Mamane, O Le Bacquer, D Shahbazian and N Sonenberg mTOR signaling: implications for cancer and anticancer therapy advance online publication, 2005-12-13 00:00:00.000; doi:10.1038/sj.bjc.6602902 Abstract | Full article | PDF |
||||||||
| Masuda, Y Y Tajima, K Yamazaki, R Makino, N Nishino, Y Masuda, S Aoki, M Kato, K Morohara and M Kusano Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach advance online publication, 2007-01-30 00:00:00.000; doi:10.1038/sj.bjc.6603583 Abstract | Full article | PDF |
||||||||
| Mataki, Y H Okumura, S Natsugoe, M Matsumoto, Y Mataki, H Takatori, S Ishigami, S Takao and T Aikou The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma advance online publication, 2005-01-18 00:00:00.000; doi:10.1038/sj.bjc.6602322 Abstract | Full article | PDF T Arigami, S Natsugoe, Y Uenosono, H Arima, Y Mataki, K Ehi, S Yanagida, S Ishigami, S Hokita and T Aikou Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer advance online publication, 2005-08-30 00:00:00.000; doi:10.1038/sj.bjc.6602739 Abstract | Full article | PDF H Shinchi, K Maemura, H Noma, Y Mataki, T Aikou and S Takao Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer advance online publication, 2007-04-17 00:00:00.000; doi:10.1038/sj.bjc.6603735 Abstract | Full article | PDF S Maeda, H Shinchi, H Kurahara, Y Mataki, H Noma, K Maemura, K Aridome, T Yokomine, S Natsugoe, T Aikou and S Takao Clinical significance of midkine expression in pancreatic head carcinoma advance online publication, 2007-07-10 00:00:00.000; doi:10.1038/sj.bjc.6603879 Abstract | Full article | PDF S Maeda, H Shinchi, H Kurahara, Y Mataki, K Maemura, M Sato, S Natsugoe, T Aikou and S Takao CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer advance online publication, 2008-03-18 00:00:00.000; doi:10.1038/sj.bjc.6604307 Abstract | Full article | PDF |
||||||||
| Matsui, Y H Kawanishi, T Takahashi, M Ito, Y Matsui, J Watanabe, N Ito, T Kamoto, T Kadowaki, G Tsujimoto, I Imoto, J Inazawa, H Nishiyama and O Ogawa Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation advance online publication, 2007-06-19 00:00:00.000; doi:10.1038/sj.bjc.6603850 Abstract | Full article | PDF |
||||||||
| Matsuki, Y Y Kohno, Y Matsuki, A Tanimoto, H Izumi, T Uchiumi, K Kohno, S Shimajiri and Y Sasaguri Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen advance online publication, 2006-02-14 00:00:00.000; doi:10.1038/sj.bjc.6602987 Abstract | Full article | PDF |
||||||||
| Matsumoto, Y O Wada-Hiraike, T Yano, T Nei, Y Matsumoto, K Nagasaka, S Takizawa, H Oishi, T Arimoto, S Nakagawa, T Yasugi, S Kato and Y Taketani The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor 
advance online publication, 2005-05-10 00:00:00.000; doi:10.1038/sj.bjc.6602614 Abstract | Full article | PDF T Iehara, H Hosoi, K Akazawa, Y Matsumoto, K Yamamoto, S Suita, T Tajiri, T Kusafuka, E Hiyama, M Kaneko, F Sasaki, T Sugimoto and T Sawada MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening advance online publication, 2006-05-02 00:00:00.000; doi:10.1038/sj.bjc.6603149 Abstract | Full article | PDF |
||||||||
| Matsumura, Y Y Matsumura, T Hamaguchi, T Ura, K Muro, Y Yamada, Y Shimada, K Shirao, T Okusaka, H Ueno, M Ikeda and N Watanabe Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin advance online publication, 2004-10-12 00:00:00.000; doi:10.1038/sj.bjc.6602204 Abstract | Full article | PDF T Hamaguchi, Y Matsumura, M Suzuki, K Shimizu, R Goda, I Nakamura, I Nakatomi, M Yokoyama, K Kataoka and T Kakizoe NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel advance online publication, 2005-03-22 00:00:00.000; doi:10.1038/sj.bjc.6602479 Abstract | Full article | PDF H Uchino, Y Matsumura, T Negishi, F Koizumi, T Hayashi, T Honda, N Nishiyama, K Kataoka, S Naito and T Kakizoe Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats advance online publication, 2005-09-13 00:00:00.000; doi:10.1038/sj.bjc.6602772 Abstract | Full article | PDF T Negishi, F Koizumi, H Uchino, J Kuroda, T Kawaguchi, S Naito and Y Matsumura NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel advance online publication, 2006-08-08 00:00:00.000; doi:10.1038/sj.bjc.6603311 Abstract | Full article | PDF T Hamaguchi, K Kato, H Yasui, C Morizane, M Ikeda, H Ueno, K Muro, Y Yamada, T Okusaka, K Shirao, Y Shimada, H Nakahama and Y Matsumura A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation advance online publication, 2007-06-26 00:00:00.000; doi:10.1038/sj.bjc.6603855 Abstract | Full article | PDF T Yoshioka, M Miyamoto, Y Cho, K Ishikawa, T Tsuchikawa, M Kadoya, L Li, R Mishra, K Ichinokawa, Y Shoji, Y Matsumura, T Shichinohe, S Hirano, T Shinohara, T Itoh and S Kondo Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma advance online publication, 2008-03-18 00:00:00.000; doi:10.1038/sj.bjc.6604294 Abstract | Full article | PDF |
||||||||
| Merrouche, Y C Massard, J-J Voigt, A Laplanche, S Culine, A Lortholary, R Bugat, C Théodore, F Priou, M-C Kaminsky, T Lesimple, X Pivot, B Coudert, J-Y Douillard, Y Merrouche and K Fizazi Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? advance online publication, 2007-09-18 00:00:00.000; doi:10.1038/sj.bjc.6603942 Abstract | Full article | PDF |
||||||||
| Mi, Y Y Mi and L Lou ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein advance online publication, 2007-10-02 00:00:00.000; doi:10.1038/sj.bjc.6603985 Abstract | Full article | PDF Y Mi and L Lou Reply: ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein advance online publication, 2007-11-06 00:00:00.000; doi:10.1038/sj.bjc.6604078 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||